Medicine and Dentistry

1. Patient 100%
2. Prostate Cancer 90%
3. Man 68%
4. Malignant Neoplasm 53%
5. Therapeutic Procedure 43%
6. Association 35%
7. COVID-19 31%
8. Analysis 30%
9. Diagnosis 24%
10. Systematic Review 23%
11. Neoplasm 22%
12. Biopsy Technique 21%
13. Mortality 17%
14. Patient with Cancer 17%
15. Cancer Risk 17%
16. Breast Cancer 16%
17. Bladder Cancer 16%
18. Follow up 15%
19. Marker 14%
20. Hazard Ratio 14%
21. Woman 14%
22. Cohort Analysis 13%
23. Randomized Controlled Trial 11%
24. Cancer Mortality 11%
25. Age 11%
26. Prostate Cancer Diagnosis 11%
27. Meta-Analysis 11%
28. Neoadjuvant Chemotherapy 10%
29. Prostate Specific Antigen 10%
30. Health 10%
31. C Reactive Protein 10%
32. Surgical Margin 10%
33. Quality of Life 9%
34. Biological Marker 9%
35. Experience 9%
36. Cancer Research 9%
37. Disease 9%
38. Magnetic Resonance Imaging 9%
39. Prostate Biopsy 9%
40. Androgen Deprivation Therapy 9%
41. Cardiovascular Disease 8%
42. Infection 8%
43. Physical Activity 8%
44. Glucose 8%
45. Maturity Onset Diabetes of the Young 8%
46. Proportional Hazards Model 8%
47. Severe Acute Respiratory Syndrome Coronavirus 2 8%
48. Cancer Therapy 7%
49. National Health and Nutrition Examination Survey 7%
50. Diabetes 7%